Clinical Trials Logo

Advanced Biliary Tract Cancer clinical trials

View clinical trials related to Advanced Biliary Tract Cancer.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05009953 Not yet recruiting - Clinical trials for Intrahepatic Cholangiocarcinoma

Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer

Start date: September 2021
Phase: Phase 2
Study type: Interventional

This study is an open-label, phase II study of irinotecan liposome injection in patients with advanced biliary tract cancer. The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics of irinotecan liposome injection in patients with advanced biliary tract cancer.

NCT ID: NCT04733521 Not yet recruiting - Clinical trials for Advanced Biliary Tract Cancer

A Phase 1/2 Study of SC-43 in Combination With Cisplatin

Start date: May 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

SC-43 is STAT3 inhibitor. Based on the phase I data of SC-43 monotherapy, this is a Phase 1/2, Open-label, Study to Investigate the Safety, Tolerability, and Efficacy of SC-43 Administered in Combination with Cisplatin in Subjects with Advanced or Refractory Non-small Cell Lung Cancer or Biliary Tract Carcinoma